The Regional Express Holdings Ltd (ASX: REX) share price has been a strong performer on Wednesday.

In morning trade the regional airline operator’s shares jumped as much as 10% to $2.07.

The Regional Express share price has since given back some of these gains but is still up 8% to $2.03 currently.

Why is the Regional Express share price soaring?

Investors have been buying the company’s shares this morning after it announced the receipt of the High Capacity Air Operator’s Certificate (HCAOC) by the Civil Aviation Safety Authority (CASA).

This means that the airline is now approved for Regular Public Transport services using the Boeing 737-800NG on its existing network where appropriate.

Why is this important?

With the HCAOC in hand and the airline able to fly its 737-800NG for Regular Public Transport services, Regional Express can now start preparing to compete with Qantas Airways Limited (ASX: QAN) and Virgin Australia on some of the busiest domestic travel routes.

The company is planning to commence domestic operations between Sydney and Melbourne from 1 March 2021 and thereafter to other major cities.

In preparation for this, it has launched a special promotion of 100,000 tickets offered at $79 on its nine daily return flights between Sydney and Melbourne.

What now?

There is expected to be some meaningful economic and traveller benefits from this development.

The company revealed that it hopes to be able to help in the national recovery effort by offering jobs to some of the thousands made redundant by other carriers during the pandemic.

Furthermore, it is looking forward to providing “domestic travellers with a safe and reliable yet affordable air service with its trademark country hospitality.”

Management spoke positively about the CASA team, acknowledging that it wouldn’t have been able to achieve this without its help.

Regional Express’ Executive Chairman, Lim Kim Hai, commented: “CASA’s commitment and dedication to the recovery effort during this period of national emergency is nothing short of outstanding and exemplary. Under the leadership of Shane Carmody and Craig Martin, CASA has gone above and beyond to ensure that the aviation industry is fully supported by the regulator in all aspects. CASA’s assistance was critical at a time when all airlines were fighting for survival.”

The good news for Qantas shareholders is that this news hasn’t put a dampener on its shares. The Qantas share price is up approximately 2% in morning trade.

More reading

• Qantas (ASX:QAN) budget flights to exceed pre-COVID levels by March
• ASX 200 rises on Monday
• Why I’m sticking with my Afterpay shares: fundie
• This is when ASX airport shares will take off
• Why this broker thinks it’s time to buy Qantas (ASX:QAN) shares

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Regional Express (ASX:REX) share price is soaring 10% higher today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/2WgbyCQ

The Pilbara Minerals Ltd (ASX: PLS) share price has returned from its trading halt on Wednesday and crashed lower.

In early trade the lithium miner’s shares were down as much as 17% to 72.5 cents.

The Pilbara Minerals share price has recovered slightly since then but is still down 13.5% to 75.7 cents at the time of writing.

Why is the Pilbara Minerals share price crashing lower?

The company’s shares have come under pressure today after it completed the institutional component of its equity raising.

According to the release, the company has raised a total of $61 million via an underwritten 1 for 7.6 pro-rata accelerated non-renounceable entitlement offer. These funds were raised at 36 cents per new share, which represents a massive 59% discount to its last close price.

This means the company has now raised a total of $180 million, following its previously completed $119 million cornerstone placement with AustralianSuper at the same price.

Pilbara Minerals will now push ahead with its retail entitlement offer, which is aiming to raise a further $60 million. This will bring its overall equity funding package to $240 million.

Why is Pilbara Minerals raising funds?

The proceeds from the equity raising will be used to fund the acquisition of the shares in Altura Lithium Operations for US$175 million. This is the company that owns Altura’s Pilgangoora Lithium Project in Western Australia.

Pilbara Minerals’ Managing Director, Ken Brinsden, commented: “We are very pleased with the extremely strong support for the Entitlement Offer shown from our institutional shareholders. This represents a clear endorsement of Pilbara Minerals’ highly strategic acquisition of the neighbouring Altura Project on an unencumbered basis.”

“The acquisition is expected to deliver significant benefits to Pilbara Minerals shareholders, including realisation of tangible operational synergies and consolidates our leading position in the Australian lithium market,” he concluded.

More reading

• Why everyone’s watching the Pilbara Minerals (ASX:PLS) share price
• Are ASX lithium shares a hot commodity right now?
• Why the PIlbara Minerals (ASX:PLS) share price is charging higher
• The 13 ASX shares that could have doubled your money in 2020
• Are ASX lithium shares making a comeback?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Pilbara Minerals (ASX:PLS) share price crashed 17% lower today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/34eR8yq

The Commonwealth Bank of Australia (ASX: CBA) share price has opened strongly, climbing more than 1.4% since market open.

Why is the CBA share price lifting?

The S&P/ASX 200 Index (ASX: XJO) is up 0.5% to 6,666 points to start the day after Wall Street climbed higher overnight on COVID-19 vaccine news.

The CBA share price is lifting in early trade after a key announcement at the stroke of the bell. Broad market positivity alongside the announcement has helped boost the ASX bank share higher.

Australia’s largest bank announced it would merge Aussie Home Loans with Lendi, a leading online home loan platform. The merger will see Aussie’s strong brand name and significant network with Lendi’s market-leading technology and existing platform.

CBA acquired 100 per cent of Aussie back in August 2017 and has steadily grown the book in subsequent years. CBA will retain a 45% shareholding in the combined business with Lendi to take the remaining 55% stake. The bank will receive deferred consideration and a pre-completion dividend of $105 million in aggregate.

CBA CEO Matt Comyn said the business will offer “enhanced digital capabilities” for Aussie brokers with an improved customer experience. Lendi CEO and co-founder David Hyman was similarly bullish, hoping the merger will “drive even stronger outcomes for more homeowners and brokers alike”.

The proposed merger is subject to ACCC approval and other conditions, with completion expected by mid-calendar year 2021.

The CBA share price has reacted positively with the Aussie bank leading the way with a 1.48%% gain this morning. Shares in the other Big Four banks are also up with Australia and New Zealand Banking GrpLtd (ASX: ANZ) and National Australia Bank Ltd (ASX: NAB) also gaining strongly.

Foolish takeaway

The Lendi merger has helped boost the CBA share price higher in early trade as the bank looks to sell down its stake in the mortgager broker business. 

More reading

• Why the Bendigo and Adelaide Bank (ASX:BEN) share price is jumping higher today
• The ASX bank with the best dividend yield under APRA’s new guidelines
• Why the Beacon Lighting (ASX:BLX) share price is on watch today
• Here’s how ASX 200 bank shares have performed in 2020 so far
• Why ASX banks are licking their lips right now

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post The Commonwealth Bank (ASX:CBA) share price is climbing higher today. Here’s why. appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/37ltzWx

The Bendigo and Adelaide Bank Ltd (ASX: BEN) share price is pushing higher in early trade despite no new announcements from the Aussie bank. This comes after rival Xinja announced its retreat from the neobank market.

Why the Bendigo and Adelaide Bank share price is on the rise

The big news today impacting the Bendigo and Adelaide Bank share price actually doesn’t come from Bendigo itself. However, one of its key neobank rivals has announced it will turn in its authorised deposit-taking institution (ADI) license and return capital to its members.

Xinja has today announced it will hand back its banking license after market pressures made the business unviable. The Aussie neobank burst onto the scene with high savings rates but no lending product in the market.

That has seen significant cash burn to pay out its account holders without any money coming in the door from lending activities. That’s despite the Australian Prudential Regulation Authority (APRA) granting Xinja the license in September 2019.

So, what does this have to do with Bendigo? The Bendigo and Adelaide Bank share price is charging higher thanks to broad market positivity and its status as a neobank competitor.

Bendigo is a key partner and collaborator in Up, another Aussie neobank founded in 2018. That means the retreat of Xinja could strengthen Up’s position in the increasingly-saturated neobank market.

It’s a similar story for National Australia Bank Ltd (ASX: NAB), which has its own neobank product via its UBank division.

The Bendigo and Adelaide Bank share price has pushed 1.2% higher in early trade while NAB shares are up 1.8% to start the day. It’s good news across most of the financial services sector with Commonwealth Bank of Australia (ASX: CBA) shares also climbing after the company announced a merger between Aussie Home Loans and Lendi.

The S&P/ASX 200 Index (ASX: XJO) has pushed 1.0% higher to nearly 6,700 points thanks to a strong performance on Wall Street overnight.

More reading

• The ASX bank with the best dividend yield under APRA’s new guidelines
• Here’s how ASX 200 bank shares have performed in 2020 so far
• Why ASX banks are licking their lips right now
• ASX 200 falls on Tuesday
• Here are the US shares ASX investors are buying

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Bendigo and Adelaide Bank (ASX:BEN) share price is jumping higher today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/38anNGr

The Global Health Limited (ASX: GLH) share price is lifting higher today after the company announced it was experiencing strong demand for its Lifecard Patient Portal. At the time of writing, the Global Health share price is up 1.12% at 45 cents.

Global Health is an Australia-based company that develops, sells and supports the application software for the healthcare sector. The business also integrates systems that allows electronic medical records, messages, and other services to be exchanged between healthcare professionals and the patient.

Robust demand for Lifecard Patient Portal

Today, Global Health advised that COVID-19 was driving unprecedented demand for digital healthcare engagement through its Lifecard Patient Portal.

The platform was soft-launched more than 3 years ago and deployed on 3 customer sites. Since March when the pandemic impacted everyday lives, Global Health installed the Lifecard Patient Portal on 12 other platforms. That has led the company to achieve a recurring revenue stream of more than $50,000 per month within 18 months.

Global Health noted that COVID-19 has accelerated demand for its products, as the population moves towards the digital healthcare space. In turn, the push into online systems gives accurate and up-to-date information from patients to medical professionals, thus improving efficiency and productivity.

Management commentary

Global Health managing director Matthew Cherian, said:

Global Health is constantly looking to enhance the doctor/patient experience and improve healthcare provider productivity and efficiency, while ensuring that patients do not get lost in administration and paperwork when seeking help for their health conditions and medical issues.

The additional cost of the Lifecard Patient Portal will generate immediate financial returns for our provider customers through time saved, reduced errors, and accurate patient health and financial information into Provider clinical systems. The bottom- line results are extremely compelling for healthcare providers.

Global Health share price performance

The Global Health share price reached a 52-week high of 60 cents last month. This came as the company announced that Western Australia had awarded a 10-year contract for MasterCare EMR.

Although, its shares have since dipped around 25%, the Global Health share price is up more than 200% for 2020.

More reading

• SelfWealth (ASX:SWF) share price higher on successful launch of US trading
• Want to make a million in the next market crash? I’d use these 3 Warren Buffett tips today
• Openpay (ASX: OPY) share price rockets up 8% after major announcement
• Why the Zoono (ASX:ZNO) share price is jumping 8% higher
• Althea (ASX:AGH) share price drops lower despite major announcement

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post The Global Health (ASX:GLH) share price is lifting today. Here’s why. appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/34gxuC2

SelfWealth Ltd (ASX: SWF) shares have been under pressure after slumping more than 30% from their 80 cent peak back in September. Despite its recent underperformance, the SelfWealth share price is still up more than 200% year to date at today’s prices.

This morning, SelfWealth shares are on the move again after the company announced the successful launch of its US trading functionality. In the opening minutes of trade, the SelfWealth share price has risen 3.7% to 56 cents. 

Plans for international trading 

SelfWealth previously announced its intentions to capture international trades in its FY20 first half results back in February 2020. The company hoped to capture international trades that investors were performing elsewhere. The service had an expected go live date of December 2020 and forecast 5,000 domestic clients to be trading US shares by June 2021. 

What’s driving the SelfWealth share price higher?

On 7 December, SelfWealth announced that US trading for its retail clients would be launching on schedule, on 14 December. 

Its existing 65,000+ active clients will now be able to submit a request to have the US trading feature added to each of their approved Australian equity portfolios. 

US trading features a USD cash account, competitive FX rates when transferring money between the AUD and USD cash accounts, low-cost and flat-fee brokerage of USD$9.50 per trade and the choice of over 7,500 US securities across all major US exchanges. 

Today, the SelfWealth share price is on the rise after the company revealed the uptake of the new service by its trading community has exceeded expectations. More than 7,000 active traders have requested the US trading feature be added to their SelfWealth portfolios in the nine days since the company announced pre registration on 7 December. 

Equally pleasing has been the increase in new account registrations since the US trading announcement on 7 December. This will continue to assist the company’s efforts of increasing customer acquisition into the new year. 

What did management say?

SelfWeath Managing Director Rob Edgley, commenting on the US trading launch had this to say:

To reach the milestone of more than 10% of SelfWealth’s existing customers registering for US trading in such a short amount of time is a significant achievement and many months ahead of our expectations.

More reading

• The Global Health (ASX:GLH) share price is lifting today. Here’s why.
• Want to make a million in the next market crash? I’d use these 3 Warren Buffett tips today
• Openpay (ASX: OPY) share price rockets up 8% after major announcement
• Why the Zoono (ASX:ZNO) share price is jumping 8% higher
• Althea (ASX:AGH) share price drops lower despite major announcement

Motley Fool contributor Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post SelfWealth (ASX:SWF) share price higher on successful launch of US trading appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3gPhSdU

Warren Buffett has previously invested money following a market crash to great effect. It has enabled him to buy high-quality companies at prices that undervalue their future prospects.

His strategy works because he is content to hold large amounts of cash ready to invest in a market decline. He also takes a long-term view of his investments, and seeks to buy businesses with wide economic moats.

Clearly, the timing of the next market crash is a known unknown. However, planning for it now could be a means of improving an investor’s prospects of making a million.

Warren Buffett’s willingness to hold cash

Warren Buffett holds a significantly greater proportion of cash within his portfolio than is often the case among other investors. Although this means lower returns when stock markets are rising, it provides him with the opportunity to capitalise on low valuations when they come along. And, with a market crash often being short in nature, having access to large amounts of liquidity can allow an investor to take advantage of temporarily cheap stock prices.

With interest rates currently at low levels, holding a substantial amount of cash may reduce an investor’s overall returns in the short run. However, the low valuations that are often available in a market decline may mean that it is worth accepting a lower return in the short run to obtain greater scope for capital appreciation over the long term.

A patient stance regarding the prospect of a market crash

Warren Buffett also takes a patient approach when managing his portfolio. This means that he is unconcerned about when a market crash will occur, or how long it will take for the stock market to recover. As a result, he is content to wait for the best opportunities to come along. Should they be unavailable at a particular point in time, he is happy to wait for shares in high-quality companies to trade at lower prices.

Looking ahead, it is unclear when the next market crash will occur. However, the past performance of the stock market suggests a downturn is always set to take place in the long run. Waiting for it to take place to buy high-quality stocks at cheap prices could be a profitable long-term move.

Seeking economic moats

Warren Buffett has previously purchased companies with wide economic moats. This is essentially a competitive advantage over their peers that can mean higher profits in a variety of market conditions. Through purchasing businesses with advantages such as strong customer loyalty and a unique product, it may be possible to generate relatively high returns in the next market crash.

Even if an investor matches the stock market’s long-term return of around 8% per year, a $100,000 investment today would become worth over a million within 30 years. However, by holding cash for better opportunities, having a patient approach and buying stocks with wide economic moats, it may be possible to obtain a higher return over the long run.

More reading

• The Global Health (ASX:GLH) share price is lifting today. Here’s why.
• SelfWealth (ASX:SWF) share price higher on successful launch of US trading
• Openpay (ASX: OPY) share price rockets up 8% after major announcement
• Why the Zoono (ASX:ZNO) share price is jumping 8% higher
• Althea (ASX:AGH) share price drops lower despite major announcement

Motley Fool contributor Peter Stephens has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Want to make a million in the next market crash? I’d use these 3 Warren Buffett tips today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/34gX9L6

The Openpay Group Ltd (ASX: OPY) share price is surging up today after a major expansion announcement from the Aussie buy now, pay later (BNPL) group. At the time of writing, the Openpay share price is trading up 8.33% at $2.34.

Why is the Openpay share price rocketing up?

Openpay has marked its first full year of trading on the ASX by reporting a record trading result. The BNPL company posted a new record month of total transaction value (TTV) with November 2020 numbers skyrocketing.

November TTV totalled $35.7 million, up from the previous Openpay record of $25.8 million. Strong Black Friday and Cyber Monday sales provided a strong boost with Black Friday 2020 representing the best day of trading in Openpay’s history.

The Openpay share price has rocketed higher in the 12 months since listing with a market capitalisation of $150 million. Shares in the BNPL group are up 74.2% so far in 2020 with Openpay now boasting a $233.3 million valuation.

Openpay UK saw significant growth in active plans, up 1,919% on the prior corresponding period (pcp) with active customers up 961% on pcp in November. The group’s UK operations now has agreements in place with 53 merchants in a sign of further growth.

What else did Openpay announce?

The other big news alongside the record monthly trading result was the group’s expansion into the United States. Openpay has started its US launch with the appointment of highly respected US industry leaders.

Openpay’s focus and strategy remains the same as in Australia and the UK, with flexible longer-term and higher-value plans in its consumer and business to business (B2B) platforms.

Openpay has touted its strong management team and extensive deal pipeline as cornerstones of the US launch. That includes new Openpay US CEO and global chief strategy officer, Brian Shniderman. Mr Shniderman joins from Deloitte where he founded and grew the firm’s ‘globally top-ranked’ payments practice.

Foolish takeaway

The Openpay share price is one to watch this morning after the latest sales and expansion news, following in the footsteps of fellow BNPL rivals Zip Co Ltd (ASX: Z1P) and Afterpay Ltd (ASX: APT).

More reading

• ASX 200 falls on Tuesday
• Creso Pharma and Nuix were among the most traded shares on the ASX last week
• ASX 200 down 0.1%: APRA removes bank dividend restrictions, Fortescue slides, Zip higher
• Zip (ASX:Z1P) share price rises on Harvey Norman (ASX:HVN) partnership
• Why the Afterpay (ASX:APT) share price is not the only rising star this year

Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Openpay (ASX: OPY) share price rockets up 8% after major announcement appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3oW3bst

The Zoono Group Ltd (ASX: ZNO) share price is among the best performers on the ASX this morning.

At the time of writing, the antimicrobial solutions provider’s shares are up 8% to $1.39.

What did Zoono announce?

This morning Zoono released an update on a number of company developments, including some large sales and distribution agreements.

One of those developments included testing of Zoono’s Z-71 Microbe Shield Surface Sanitiser by the Dubai Central Laboratory Department.

That test observed that there is a complete reduction of test bacteria (99.9%) on all provided material surfaces till 30 days from the initial coating, except in Rubber and Wood surfaces. The rubber and wood surface has some viable growth on the 30th day with a reduction of 90% test bacteria.

Additional testing undertaken by Intertek Caleb Brett in Dubai found a 100% reduction between the slide control recovery level and Zoono Z-71 recovery level at 24 hours, 7 days, and 30 days.

Following this comprehensive testing, Zoono has now received the Emirates Authority for Standardisation and Metrology (ESMA) Certificate of Conformity.

Supply agreements.

In light of this certification, the company has entered into a supply agreement with Fine Hygienic Paper in the Emirates and has received the initial NZ$1.5 million deposit against the first-year purchases.

The overall agreement is for five years and has minimum annual performance target volumes of NZ$21.5 million for the first 12 months. After which, it has target volumes of NZ$28.5 million in the second year, NZ$35.7 million in the third year, and then a 5% increase thereafter.

Zoono also revealed a three-year agreement in Russia with hygiene services company ECO-SALUS. By the end of the term, its volumes are expected to be a minimum of NZ$5 million a year.

New product launch.

A final development has been the launch of a new product, which management notes is diversifying its range of antimicrobial products.

The new product is a face mask treated with Zoono, protecting the wearer from pathogens over a period of time.

But this may not be the last product launch. Management advised that it continues to work with its globally recognised customers and distributors with the aim of developing new products to help them protect their staff, customers, and communities.

More reading

• Althea (ASX:AGH) share price drops lower despite major announcement
• Why the Pushpay (ASX:PPH) share price is tumbling lower today
• Why the Resolute Mining (ASX:RSG) share price is charging higher today
• The ASX bank with the best dividend yield under APRA’s new guidelines
• Why the Beacon Lighting (ASX:BLX) share price is on watch today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Zoono (ASX:ZNO) share price is jumping 8% higher appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3af6FST

The Althea Group Holdings Ltd (ASX: AGH) share price is out of form on Wednesday despite the release of a positive announcement.

In morning trade the cannabis company’s shares are down 2% to 49 cents.

Why is the Althea share price dropping lower?

Investors have been selling the company’s shares this morning despite it announcing that a major regulatory change has been confirmed in Australia. This change is in relation to the status of cannabidiol (CBD) in Australia.

According to the release, the Therapeutic Goods Administration (TGA) has issued its final decision on proposed amendments to the Poison Standard. These amendments will see a new Schedule 3 (Pharmacist Only Medicine) entry created for CBD.

The date of effect of the decision is 1 February 2021, which is much sooner than the original anticipated date of 1 June 2021.

What does this mean?

The amendment will allow CBD to be supplied for therapeutic use under a new Schedule 3 entry.

This new cannabis channel would allow Australian patients to purchase CBD products over the counter upon consultation with a pharmacist, without the need for a prescription.

In addition to this, the final decision includes a modification to the dose specified in the interim decision. It has been increased from 60 mg/day, up to 150 mg/day.

Althea believes the decision paves the way for its top selling full-spectrum CBD product, Althea CBD100, to be made available under Schedule 3. It is currently sold under Schedule 4, which makes it a Prescription Only Medicine.

Management commentary.

Althea’s CEO, Josh Fegan, commented: “We applaud the TGA’s final decision in this matter and are glad to see the administration listened to industry following the interim decision, and subsequently decided to increase the maximum recommended daily dose acknowledging that this dose is consistent with the expected safety profile of a Schedule 3 medicine.

“The final decision follows the Company’s announcement to shareholders that it had raised additional working capital, through an institutional placement, with a portion of those funds allocated towards the product development and registration of a range of CBD products for the potential Schedule 3 market in Australia. This decision provides confirmation of that marketplace and the Company can now proceed with its plans to have over the counter Althea products available for Australian patients in 2021,” he added.

More reading

• Cannabis share Althea (ASX:AGH) sinks 11% on capital raising and Aphria selldown
• Why Althea, Altium, Fortescue, & Retail Food Group are dropping lower
• Why cannabis company Althea (ASX:AGH) is storming higher today
• Althea (ASX:AGH) share price lifts 10% today. Here’s why
• Why the Althea (ASX:AGH) share price soared 6% today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Althea (ASX:AGH) share price drops lower despite major announcement appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3qW3vtb